Prognostic Factors in Small-Cell Lung Cancer and Quality of Life During Chemotherapy
Author Information
Author(s): J Bernhard, C Hürny, M Bacchi, RA Joss, F Cavalli, H-J Senn, S Leyvraz, R Stahel, C Ludwig, P Alberto
Primary Institution: Swiss Group for Clinical Cancer Research (SAKK)
Hypothesis
Do initial prognostic factors predict quality of life during chemotherapy in patients with small-cell lung cancer?
Conclusion
Initial tumour stage, performance status, and previous weight loss can predict quality of life during chemotherapy.
Supporting Evidence
- Patients with poor prognostic factors reported worse quality of life.
- Older patients reported worse fatigue and malaise.
- Patients with extensive disease reported worse general and emotional well-being.
- Patients with greater weight loss reported worse fatigue and malaise.
Takeaway
Doctors can tell how well a lung cancer patient might feel during treatment by looking at their health before starting chemotherapy.
Methodology
A multicentre, randomised, phase III trial comparing early and late alternating chemotherapy in patients with small-cell lung cancer.
Potential Biases
Attrition bias due to increasing drop-out rates over time.
Limitations
Missing data and small sample sizes may limit the findings.
Participant Demographics
Patients included both males and females, with varying ages and performance statuses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website